Ansell Healthcare Products LLC announces it has won a silver MM&M (Medical Marketing & Media) award this fall in recognition of its “Power of Pink” campaign for the launch of its Micro-Touch® NitraFree™ nitrile exam gloves.
MM&M announced the honor at its 2009 Award Show, held October 29 at in New York City. The awards recognize the marketing and advertising effectiveness of healthcare companies throughout the United States.
“A great, simple idea,” said judges for the MM&M Award, who included senior executives from Merck, Pfizer, Johnson & Johnson, Novartis, AstraZeneca and other leading healthcare companies. More than 700 submissions were considered for awards this year.
The “Power of Pink” campaign was aimed at generating awareness among healthcare personnel in hospitals and clinics for Ansell's “anti-allergies” nitrile examination glove, Micro-Touch® NitraFree™, and promoting a fundraising partnership with Susan G. Komen for the Cure®, the world’s largest breast cancer advocacy organization.
Creative director Todd Mecca said, “Our primary goal was to create an effective marketing campaign that would truly engage Ansell’s audience; a campaign that gave everyone the opportunity to support this worthy cause. Many members of our team at Q&B have had a brush with this horrible disease, so we understand the importance of making even a small difference in the fight for the cures. Empowering the healthcare community to make a difference was critical to the success of the campaign – we wanted to give them the opportunity to partner with Ansell and Susan G. Komen for the Cure to help win the battle. We gave practitioners a way to share their emotions, and love at AORN 2008 and 2009 by signing a hand and displaying it upon the Wall of Empowerment for 5,000 of their peers to share.”
For each glove affixed to the wall, Ansell donated $1 to Susan G. Komen for the Cure. At the same time, nurses learned how the sale of every Micro-Touch® NitraFree™ glove would continue to support breast cancer awareness and research through Komen for the Cure.
“We are so proud to be honored for this campaign,” said Patty Taylor, vice president of marketing – North America, of Ansell Healthcare. “Not only did we make a big impact with an important new product that will help healthcare practitioners do their jobs more safely and effectively – but it’s so gratifying to be raising funds and awareness for Susan G. Komen for the Cure at the same time.”
“This campaign was rewarding in so many ways,” explained Emily Spensieri, president of Q&B Healthcare. “Our first reward came at the trade show, experiencing the incredible sense of community created at the Wall of Empowerment when nurses came together to share their stories. Then came the rewards of unprecedented leads – and the sales that followed. And now, being recognized for the MM&M award? It’s the cherry on top. We are so pleased to have won this award for a campaign that’s so close to our hearts.”
Implementing FDA 21 CFR Part 820 & ISO 13485 on Quality System Regulation
August 30th 2024The FDA's 21 CFR Part 820 and ISO 13485 are crucial in regulating medical device quality systems. Harmonizing these standards by 2026 will streamline compliance, improve patient access to devices, and align US regulations with global practices.
The Long-Term Care Chronicles: The Great Mitigators
August 27th 2024Enjoy this first installment of The Long-Term Care Chronicles With Robbie Hilliard, MSN, RN CIC, a column about managing special infection control situations in the long-term care patient population. This installment is about when 2 experts conflict about best care.
Urgent Need for a Paradigm Shift in Infectious Disease Control Amid 2024 Outbreaks
August 26th 2024The 2024 surge in infectious diseases like mpox, measles, and meningitis demands a paradigm shift in control strategies, emphasizing expanded expertise, improved airborne precautions, and rethinking cost-effectiveness in healthcare to prevent future outbreaks and protect public health.
Navigating Infection Prevention Challenges Amid 2024 Outbreaks: Strategies for Success
August 22nd 2024As infectious diseases resurge in 2024, this article explores how IPs can manage outbreaks, allocate resources, use technology for surveillance, and collaborate with senior leaders to ensure business continuity and patient safety in health care settings.